minimum bid price

Biodexa Pharmaceuticals executes 1-for-5 reverse ADR split effective April 6, 2026, to maintain Nasdaq listing compliance with minimum bid price requirements.

Lifeward Ltd. ($LFWD) has regained compliance with Nasdaq's $1.00 minimum bid price requirement, ending delisting risk for the medical technology company.

New Century Logistics ($NCL) restored Nasdaq compliance by maintaining $1.00+ share price for 12 consecutive days, ending non-compliance notice issued in August 2025.

InterCure receives Nasdaq non-compliance notice for falling below $1.00 minimum bid price. Company has 180 days to recover or face delisting.

Creatd completed a 1-for-20 reverse stock split on February 24 to meet exchange listing requirements and minimum bid price thresholds. No financing activities accompany the technical restructuring.

Trinity Biotech received a Nasdaq delisting warning after failing to maintain the $1.00 minimum bid price. The company has until August 2026 to restore compliance or face delisting.